Summary
A federal legal proceeding in Kansas, initiated by Mr. Crews and supported by the American Civil Liberties Union (ACLU), was rendered moot following a settlement. The Bureau of Prisons agreed to continue Mr. Crews’s Medication-Assisted Treatment (MAT) with buprenorphine. This decision aligns with updated policies under the First Step Act, thereby eliminating the potential for treatment denial.
Summary
A federal court case in Kansas, supported by the American Civil Liberties Union on behalf of an individual named Crews, was declared moot after the Bureau of Prisons reached an agreement. The resolution ensured the continued provision of Crews's Medication-Assisted Treatment (MAT) with buprenorphine, in accordance with updated policy under the First Step Act. This outcome removed the potential for his treatment to be denied.
Summary
A federal court case in Kansas involving an individual named Crews, who received support from the ACLU, has concluded. The lawsuit became unnecessary after the Bureau of Prisons agreed to continue Mr. Crews's medication-assisted treatment (MAT) with buprenorphine. This agreement followed updated policies from the First Step Act, which eliminated the possibility of his treatment being denied.
Summary
A man named Mr. Crews started a court case in Kansas. He had help from a group called the ACLU. Mr. Crews wanted to keep getting his medicine for addiction, which is called buprenorphine. The prison system agreed to let him continue getting his medicine. This decision happened because of a new rule. Because the prison system agreed, the court case did not need to be decided anymore. Mr. Crews would not lose his medicine.